Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 3, 2000, Pages 551-560

  Ling, C Clifton ^a   Humm, John ^a   Larson, Steven ^a   Amols, Howard ^a   Fuks, Zvi ^a   Leibel, Steven ^a   Koutcher, Jason A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Biological imaging; Conformal radiotherapy

Indexed keywords

CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; IMAGING SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIOSENSITIVITY; REVIEW; SPECTROSCOPY;

EID: 0034213897     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00467-3     Document Type: Article

References (80)

1. Kayyem J.F., Kumar R.M., Fraser S.E., Meade T.J. Receptor-targeted co-transport of DNA and magnetic resonance contrast agents. Chem Biol. 2:1995;615-620.
2. Moore A., Basilion J.P., Chiocca E.A., Weissleder R. Measuring transferrin receptor gene expression by NMR imaging. Biochim Biophys Acta. 1402:1998;239-249.
3. Weissleder R., Simonova M., Bogdanova A., Bredow S., Enochs W.S., Bogdanov A. Jr. MR imaging and scintigraphy of gene expression through melanin induction. Radiology. 204:1997;425-429.
4. Urbain J.L. Oncogenes, cancer and imaging. J Nuclear Med. 40:1999;498-504.
5. Hamilton R.J., Sweeney P.J., Pelizzari C.A., et al. Functional imaging in treatment planning of brain lesions. Int J Radiat Oncol Biol Phys. 37:1997;181-188.
6. Ling C.C., Burman C., Chui C.S., et al. Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. [see comments] Int J Radiat Oncol Biol Phys. 35:1996;721-730.
7. Ling C.C., Fuks Z. Conformal radiation treatment A critical appraisal . Eur J Cancer. 5:1995;799-803.
8. Bortfeld T., Burkelbach J., Boesecke R., Schlegel W. Methods of image reconstruction from projections applied to conformation radiotherapy. Phys Med Biol. 35:1990;1423-1434.
9. Mohan R., Wang X., Jackson A., et al. The potential and limitations of the inverse radiotherapy technique. Radiother Oncol. 32:1994;232-248.
10. Spirou S.V., Chui C.S. A gradient inverse planning algorithm with dose-volume constraints. Med Phys. 25:1998;321-333.
11. Burman C., Chui C.S., Kutcher G., et al. Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator A strategy for large-scale implementation for the treatment of carcinoma of the prostate . Int J Radiat Oncol Biol Phys. 39:1997;863-873.
12. Bartelink H., Begg A., Coco Martin J., et al. Towards prediction and modulation of treatment response. Radiother Oncol. 50:1999;1-12.
13. 31P magnetic resonance. J Biol Chem. 248:1973;7276-7278.
14. Koutcher J.A., Alfieri A.A., Devitt M.L., et al. Quantitative changes in tumor metabolism, partial pressure of oxygen, and radiobiological oxygenation status postradiation. Cancer Res. 52:1992;4620-4627.
15. Okunieff P., Walsh C.S., Vaupel P., et al. Effects of hydralazine on in vivo tumor energy metabolism, hematopoietic radiation sensitivity, and cardiovascular parameters. Int J Radiat Oncol Biol Phys. 16:1989;1145-1148.
16. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis Correlation in invasive breast carcinoma . N Engl J Med. 324:1991;1-8.
17. Kaiser W.A., Zeitler E. MR imaging of the breast Fast imaging sequences with and without Gd-DTPA. Preliminary observations . Radiology. 170:(3 Pt 1):1989;681-686.
18. Weidner N., Folkman J., Pozza F., et al. Tumor angiogenesis A new significant and independent prognostic indicator in early-stage breast carcinoma . [see comments] J Natl Cancer Inst. 84:1992;1875-1887.
19. Mussurakis S., Buckley D.L., Horsman A. Dynamic MR imaging of invasive breast cancer Correlation with tumour grade and other histological factors . Br J Radiol. 70:1997;446-451.
20. Le Bihan D., Breton E., Lallemand D., Grenier P., Cabanis E., Laval-Jeantet M. MR imaging of intravoxel incoherent motions Application to diffusion and perfusion in neurologic disorders . Radiology. 161:1986;401-407.
21. Tien R.D., Felsberg G.J., Friedman H., Brown M., MacFall J. MR imaging of high-grade cerebral gliomas Value of diffusion-weighted echoplanar pulse sequences . AJR Am J Roentgenol. 162:1994;671-677.
22. Krabbe K., Gideon P., Wagn P., Hansen U., Thomsen C., Madsen F. MR diffusion imaging of human intracranial tumours. Neuroradiology. 39:1997;483-489.
23. Ichikawa T., Haradome H., Hachiya J., Nitatori T., Araki T. Diffusion-weighted MR imaging with a single-shot echoplanar sequence Detection and characterization of focal hepatic lesions . AJR Am J Roentgenol. 170:1998;397-402.
24. Kim K.H., Relkin N.R., Lee K.M., Hirsch J. Distinct cortical areas associated with native and second languages. Nature. 388:1997;171-174.
25. Belliveau J.W., Kennedy D.N. Jr, McKinstry R.C., et al. Functional mapping of the human visual cortex by magnetic resonance imaging. Science. 254:1991;716-719.
26. Kim S.G., Ashe J., Hendrich K., et al. Functional magnetic resonance imaging of motor cortex Hemispheric asymmetry and handedness . Science. 261:1993;615-617.
27. Fried I., Nenov V.I., Ojemann S.G., Woods R.P. Functional MR and PET imaging of rolandic and visual cortices for neurosurgical planning. J Neurosurg. 83:1995;854-861.
28. 3) spatial resolution. Radiology. 198:1996;795-805.
29. Kaji Y., Kurhanewicz J., Hricak H., et al. Localizing prostate cancer in the presence of postbiopsy changes on MR images Role of proton MR spectroscopic imaging . Radiology. 206:1998;785-790.
30. Kurhanewicz J., Vigneron D.B., Hricak H., et al. Prostate cancer Metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging . Radiology. 200:1996;489-496.
31. Parivar F., Hricak H., Shinohara K., et al. Detection of locally recurrent prostate cancer after cryosurgery Evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy . Urology. 48:1996;594-599.
32. Wald L.L., Nelson S.J., Day M.R., et al. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg. 87:1997;525-534.
33. 1H-spectroscopy Preliminary study . Anticancer Res. 16:1996;1581-1585.
34. Tedeschi G., Lundbom N., Raman R., et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas A serial proton magnetic resonance spectroscopy imaging study . J Neurosurg. 87:1997;516-524.
35. 1H nuclear magnetic resonance study of cerebral hypoxia in vivo. Proc Natl Acad Sci USA. 80:1983;4945-4948.
36. Schwickert G., Walenta S., Sundfor K., Rofstad E.K., Mueller-Klieser W. Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res. 55:1995;4757-4759.
37. Walenta S., Salameh A., Lyng H., et al. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol. 150:1997;409-415.
38. Bhujwalla Z.M., Glickson J.D. Detection of tumor response to radiation therapy by in vivo proton MR spectroscopy. Int J Radiat Oncol Biol Phys. 36:1996;635-639.
39. 31P nuclear magnetic resonance spectroscopy. Cancer Res. 54:1994;4885-4891.
40. 31P NMR spectroscopy. NMR Biomed. 8:1995;149-158.
41. Freyer JP. Phosphomonoesters and growth fraction in multicellular spheroids. Baltimore, MD: International Society of Magnetic Resonance in Medicine, Johns Hopkins University; Aug. 8-9, 1996.
42. Freyer J.P., Schor P.L., Jarrett K.A., Neeman M., Sillerud L.O. Cellular energetics measured by phosphorous nuclear magnetic resonance spectroscopy are not correlated with chronic nutrient deficiency in multicellular tumor spheroids. Cancer Res. 51:1991;3831-3837.
43. 31P NMR analyses of phosphocholine metabolism in rat glioma cells. Magnetic Reson Med. 32:1994;310-318.
44. Dewhirst M.W., Sostman H.D., Leopold K.A., et al. Soft-tissue sarcomas MR imaging and MR spectroscopy for prognosis and therapy monitoring. Work in progress . Radiology. 174:(3 Pt 1):1990;847-853.
45. Prescott D.M., Charles H.C., Sostman H.D., et al. Therapy monitoring in human and canine soft tissue sarcomas using magnetic resonance imaging and spectroscopy. Int J Radiat Oncol Biol Phys. 28:1994;415-423.
46. Brizel D.M., Scully S.P., Harrelson J.M., et al. Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res. 56:1996;5347-5350.
47. 18F]FDG positron emission tomography in primary breast cancer Clinical relevance and practicability . Eur J Nuclear Med. 23:1996;618-623.
48. Rigo P., Paulus P., Kaschten B.J., et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nuclear Med. 23:1996;1641-1674.
49. Utech C.I., Young C.S., Winter P.F. Prospective evaluation of fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry. Eur J Nuclear Med. 23:1996;1588-1593.
50. Avril N., Bense S., Ziegler S.I., et al. Breast imaging with fluorine-18-FDG PET Quantitative image analysis . J Nuclear Med. 38:1997;1186-1191.
51. Brock C.S., Meikle S.R., Price P. Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology? [see comments] Eur J Nuclear Med. 24:1997;691-705.
52. 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer. 19:1998;167-177.
53. Munley M.T., Marks L.B., Scarfone C., et al. Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer Challenges and prospects . Lung Cancer. 23:1999;105-114.
54. Haberkorn U., Strauss L.G., Dimitrakopoulou A., et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nuclear Med. 32:1991;1485-1490.
55. Minn H., Lapela M., Klemi P.J., et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nuclear Med. 38:1997;1907-1911.
56. Fischman A.J., Thornton A.F., Frosch M.P., Swearinger B., Gonzalez R.G., Alpert N.M. FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma. J Nuclear Med. 38:1997;1027-1029.
57. Tjuvalev J.G., Macapinlac H.A., Daghighian F., et al. Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridine. J Nuclear Med. 35:1994;1407-1417.
58. Shields A.F., Mankoff D.A., Graham M.M., et al. Monitoring tumor response to chemotherapy with [C-11]-thymidine and FDG PET. J Nuclear Med. 37:1998;290-296.
59. Shields A.F., Mankoff D.A., Link J.M., et al. Carbon-11-thymidine and FDG to measure therapy response. J Nuclear Med. 39:1998;1757-1762.
60. Hara T., Kosaka N., Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nuclear Med. 39:1998;990-995.
61. Thomlinson R.H., Gray L.H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer. 9:1955;539-549.
62. Overgaard J., Horsman M.R. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol. 6:1996;10-21.
63. Hockel M., Schlenger K., Mitze M., Schaffer U., Vaupel P. Hypoxia and radiation response in human tumors. Semin Radiat Oncol. 6:1996;3-9.
64. Brizel D.M., Scully S.P., Harrelson J.M., et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56:1996;941-943.
65. Hockel M., Schlenger K., Aral B., Mitze M., Schaffer U., Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:1996;4509-4515.
66. 18F]fluoromisonidazole A pretherapy study of 37 patients . Int J Radiat Oncol Biol Phys. 36:1996;417-428.
67. Chapman J.D., Engelhardt E.L., Stobbe C.C., Schneider R.F., Hanks G.E. Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays. Radiother Oncol. 46:1998;229-237.
68. Blankenberg F., Katsikis P., Tait J., et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA. 95:1998;6349-6354.
69. Vriens P., Blankenberg F., Stoot J., et al. The use of technetium Tc 99m Annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. J Thorac Cardiovasc Surg. 116:1998;844-853.
70. Tjuvajev J.G., Finn R., Watanabe K., et al. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression A potential method for monitoring clinical gene therapy . Cancer Res. 56:1996;4087-4095.
71. Larson S.M., Tjuvajev J., Blasberg R. Triumph over mischance A role for nuclear medicine in gene therapy . [editorial; comment] [see comments] J Nuclear Med. 38:1997;1230-1233.
72. 2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector-mediated gene transfer. [see comments] J Nuclear Med. 38:1997;1221-1229.
73. Nunez M.I., McMillan T.J., Valenzuela M.T., Ruiz de Almodovar J.M., Pedraza V. Relationship between DNA damage, rejoining and cell killing by radiation in mammalian cells. Radiother Oncol. 39:1996;155-165.
74. Li G.C., Ouyang H., Li X., et al. Ku70 A candidate tumor suppressor gene for murine T cell lymphoma . Molec Cell. 2:1998;1-8.
75. Ling C.C., Endlich B. Radioresistance induced by oncogenic transformation. Radiat Res. 120:1989;267-279.
76. McKenna W.G., Weiss M.C., Endlich B., et al. Synergistic effect of the V-myc oncogene with H-ras on radioresistance. Cancer Res. 50:1990;97-102.
77. Bristow R.G., Benchimol S., Hill R.P. The p53 gene as a modifier of intrinsic radiosensitivity Implications for radiotherapy . Radiother Oncol. 40:1996;197-223.
78. Brown J.M., Wouters B.G. Apoptosis, p53 and tumor cell sensitivity to anticancer agents. Cancer Res. 59:1999;1391-1399.
79. Austin-Seymour M., Chen G.T., Rosenman J., Michalski J., Lindsley K., Goitein M. Tumor and target delineation Current research and future challenges . Int J Radiat Oncol Biol Phys. 33:1995;1041-1052.
80. Raleigh J.A., Dewhirst M.W., Thrall D.E. Measuring tumor hypoxia. Semin Radiat Oncol. 6:1996;37-45.